InxMed Presents Data regarding Potential Novel Way to Improve Therapeutic Window of ADC by Ifebemtinib and FIC ADC at 15th Annual World ADCInxMed is developing ifebemtinib to enhance ADC effectiveness by reducing fibrotic barriers in tumors.